Recurrent varicella following steroids and fingolimod in a Multiple Sclerosis patient.

作者信息

Ferraro D, De Biasi S, Vitetta F, Simone A M, Federzoni L, Borghi V, Cossarizza A, Nichelli P F, Sola P

机构信息

Neurology Unit, Department of Neurosciences, University of Modena and Reggio Emilia, Nuovo Ospedale Civile Sant'Agostino Estense, Via Pietro Giardini, 1355, 41126, Modena, Italy,

出版信息

J Neuroimmune Pharmacol. 2013 Dec;8(5):1059-61. doi: 10.1007/s11481-013-9510-4. Epub 2013 Oct 27.

DOI:10.1007/s11481-013-9510-4

PMID:24163092

Abstract

摘要

相似文献

[1]

Recurrent varicella following steroids and fingolimod in a Multiple Sclerosis patient.

J Neuroimmune Pharmacol. 2013-12

[2]

Fingolimod modulates peripheral effector and regulatory T cells in MS patients.

J Neuroimmune Pharmacol. 2013-12

[3]

Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up study.

PLoS One. 2014-10-31

[4]

MS clinical trials: what can subgroup analyses teach us?

Lancet Neurol. 2012-5

[5]

Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis--insights into possible drug mechanism.

Eur J Clin Pharmacol. 2014-3

[6]

FTY720 and central memory: out of sight, out of mind.

Neurology. 2010-8-3

[7]

Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis.

J Neuroimmunol. 2014-1-23

[8]

Fingolimod and sphingosine-1-phosphate--modifiers of lymphocyte migration.

N Engl J Med. 2006-9-14

[9]

Multiple sclerosis: Cladribine--a contentious therapeutic contender for MS.

Nat Rev Neurol. 2011-7-12

[10]

[Dilemma of further therapeutic step in remitting-relapsing multiple sclerosis in case of ineffectiveness of first-line treatment: fingolimod or natalizumab?].

Ideggyogy Sz. 2014-3-30

引用本文的文献

[1]

Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells.

Cells. 2025-4-17

[2]

Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients.

Cells. 2021-11-26

[3]

Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.

Int J Mol Sci. 2015-9-10

[4]

Infection risk in patients on multiple sclerosis therapeutics.

CNS Drugs. 2015-3

本文引用的文献

[1]

T-cell response against varicella-zoster virus in fingolimod-treated MS patients.

Neurology. 2013-5-22

[2]

Fingolimod modulates peripheral effector and regulatory T cells in MS patients.

J Neuroimmune Pharmacol. 2013-12

[3]

Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.

Neurology. 2012-11-6

[4]

Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR(+)-Treg-cells in transplanted patients.

Transpl Immunol. 2012-9-26

[5]

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

N Engl J Med. 2010-1-20

[6]

Natural regulatory T cells and persistent viral infection.

J Virol. 2008-1

[7]

Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia.

Pediatrics. 2005-10

[8]

Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens.

J Virol. 2004-3

[9]

CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses.

J Exp Med. 2003-9-15

[10]

A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination.

Pediatrics. 2003-8

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Recurrent varicella following steroids and fingolimod in a Multiple Sclerosis patient.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献